GNI Group Ltd.

Tokyo‑based GNI Group Ltd. develops and sells oncology & respiratory drugs, with Etuary in Phase III for idiopathic pulmonary fibrosis and a pipeline of liver, COPD and cardio‑pulmonary candidates in advanced trials.

Headquarters: Japan (JPN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Alternative Medicine

Employees: 867
HQ: Tokyo

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
2160	GNI Group Ltd. Cap: 152.9B	EQUITY	JPX	JPY	JP3386370005	Active	📈